David I. Marks
- Hematology top 0.05%
- Hematopoietic Stem Cell Transplantation 63
- Chronic Myeloid Leukemia Treatments 45
- Acute Myeloid Leukemia Research 29
- Transplantation top 1%
- Genetics top 0.5%
- Chronic Lymphocytic Leukemia Research 17
-
- Acute Lymphoblastic Leukemia research 81
- Oncology top 1%
- CAR-T cell therapy research 21
-
- Childhood Cancer Survivors' Quality of Life 19
-
- Lymphoma Diagnosis and Treatment 11
- Co-authors
- Lucy YardleyHillard M. LazarusMartin S. TallmanMark R. LitzowAdele K. FieldingRichard E. ChamplinJacob M. RoweAndrew McMillan
- Cited by
- HematologyTransplantationGenetics
- Journals
- Blood (38 papers)Biology of Blood and Marrow Transplantation (26 papers)British Journal of Haematology (20 papers)
- Partner nations
- United KingdomUnited StatesGermany
In The Last Decade
David I. Marks
153 papers receiving 9.6k citations
Hit Papers
Peers
Comparison fields: 5 of 175
- Hematology 6.4k
- Transplantation 391
- Genetics 1.5k
- Public Health, Environmental and Occupational Health 3.9k
- Oncology 2.6k
Countries citing papers authored by David I. Marks
This map shows the geographic impact of David I. Marks's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David I. Marks with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David I. Marks more than expected).
Fields of papers citing papers by David I. Marks
This network shows the impact of papers produced by David I. Marks. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David I. Marks. The network helps show where David I. Marks may publish in the future.
Co-authorship network
The 25 scholars most cited alongside David I. Marks, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 1 | |
| 2 | 2024 | 5 | |
| 3 | 2021 | 36 | |
| 4 | 2019 | 3 | |
| 5 | 2019 | 16 | |
| 6 | 2017 | 108 | |
| 7 | 2017 | 13 | |
| 8 | 2016 | 110 | |
| 9 | 2015 | 12 | |
| 10 | 2014 | 51 | |
| 11 | 2011 | 105 | |
| 12 | 2011 | 167 | |
| 13 | 2010 | 338 | |
| 14 | 2010 | 397 | |
| 15 | 2010 | 69 | |
| 16 | In adults with standard-risk acute lymphoblastic leukemia, the greatest benefit is achieved from a matched sibling allogeneic transplantation in first complete remission, and an autologous transplantation is less effective than conventional consolidation/maintenance chemotherapy in all patients: final results of the International ALL Trial (MRC UKALL XII/ECOG E2993)breakdown → | 2007 | 537 |
| 17 | 2006 | 0 | |
| 18 | 2005 | 131 | |
| 19 | Research Methods for Clinical and Health Psychologybreakdown → | 2004 | 659 |
| 20 | 2000 | 103 |
About David I. Marks
David I. Marks is a scholar working on Hematology, Transplantation and Public Health, Environmental and Occupational Health, having authored 162 papers that have together received 9.8k indexed citations. Recurring topics across this work include Acute Lymphoblastic Leukemia research (81 papers), Hematopoietic Stem Cell Transplantation (63 papers), Chronic Myeloid Leukemia Treatments (45 papers), Acute Myeloid Leukemia Research (29 papers), CAR-T cell therapy research (21 papers), Childhood Cancer Survivors' Quality of Life (19 papers), Chronic Lymphocytic Leukemia Research (17 papers) and Lymphoma Diagnosis and Treatment (11 papers). The work is most often cited by research in Hematology (6.4k citations), Transplantation (391 citations) and Genetics (1.5k citations). David I. Marks has collaborated with scholars based in United Kingdom, United States and Germany. Frequent co-authors include Lucy Yardley, Hillard M. Lazarus, Martin S. Tallman, Mark R. Litzow, Adele K. Fielding, Richard E. Champlin, Jacob M. Rowe, Andrew McMillan, Mary M. Horowitz and Selina M. Luger. Their work appears in journals such as Blood, Biology of Blood and Marrow Transplantation, British Journal of Haematology, Journal of Clinical Oncology and Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.